{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:30:25Z","timestamp":1760369425626},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.compbiolchem.2017.09.006","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T01:45:50Z","timestamp":1506044750000},"page":"57-62","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["QSAR study of pyrazolo[4,3-e][1,2,4]triazine sulfonamides against tumor-associated human carbonic anhydrase isoforms IX and XII"],"prefix":"10.1016","volume":"71","author":[{"given":"Joanna","family":"Matysiak","sequence":"first","affiliation":[]},{"given":"Alicja","family":"Skrzypek","sequence":"additional","affiliation":[]},{"given":"Pawe\u0142","family":"Tarasiuk","sequence":"additional","affiliation":[]},{"given":"Mariusz","family":"Mojzych","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/14756366.2014.948435","article-title":"Exploring QSARs of some benzenesulfonamides incorporating cyanoacrylamide moieties as a carbonic anhydrase inhibitors (specifically against tumor-associated isoforms IX and XII)","volume":"30","author":"Alafeefy","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/14756366.2012.727410","article-title":"More effective dithiocarbamate derivatives inhibiting carbonic anhydrases, generated by QSAR and computational design","volume":"28","author":"Avram","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.chemolab.2014.05.010","article-title":"A novel variable reduction method adapted from space-filling designs","volume":"136","author":"Ballabio","year":"2014","journal-title":"Chemometr. Intell. Lab."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0020","unstructured":"Codessa pro 1.0, University of Florida 2001\u20132002, http:\/\/www.codessa-pro.com\/."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0025","series-title":"BuildQSAR","author":"Gaudio","year":"2009"},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","article-title":"Beware of q(2)!","volume":"20","author":"Golbraikh","year":"2002","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0035","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1016\/j.bmcl.2004.03.099","article-title":"Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides","volume":"14","author":"Jaiswal","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/qsar.200510161","article-title":"On selection of training and test sets for the development of predictive QSAR models","volume":"25","author":"Leonard","year":"2006","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0045","series-title":"Designer 3.0","author":"MedChem","year":"2014"},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0050","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bmc.2005.09.038","article-title":"QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices","volume":"14","author":"Melagraki","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.compbiolchem.2017.09.006_bib0055","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00044-016-1617-8","article-title":"QSAR model development for studying carbonic anhydrase inhibitors as anticonvulsant agents","volume":"25","author":"Mishra","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0060","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.bmc.2014.03.029","article-title":"Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity","volume":"22","author":"Mojzych","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0065","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1016\/j.bmc.2015.04.011","article-title":"New pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors","volume":"23","author":"Mojzych","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0070","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.bmc.2015.02.026","article-title":"New approaches to the synthesis of sildenafil analogues and their enzyme inhibitory activity","volume":"23","author":"Mojzych","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0075","first-page":"599","article-title":"BuildQSAR: a new computer program for QSAR studies","volume":"19","author":"Oliveira","year":"2001","journal-title":"Mol. Inform."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0080","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.bmc.2012.10.029","article-title":"New selective carbonic anhydrase IX inhibitors: synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides","volume":"21","author":"Rogez-Florent","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.compbiolchem.2017.09.006_bib0085","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3390\/molecules14051660","article-title":"On two novel parameters forvalidation of predictive QSAR models","volume":"14","author":"Roy","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0090","unstructured":"Roy, K., QSAR model development using DTC Lab. Software Tools, http:\/\/teqip.jdvu.ac.in\/QSAR_Tools (Accessed 16 July 07)."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1747-0285.2007.00625.x","article-title":"Comparative QSAR study on para-substituted aromatic sulphonamides as CAII inhibitors: information versus topological (distance-based and connectivity) indices","volume":"71","author":"Singh","year":"2008","journal-title":"Chem. Biol. Drug. Des."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/157340608783331461","article-title":"Estimation of human carbonic anhydrase II inhibition using topological indices and their combination with quantum-theoretical descriptors","volume":"4","author":"Singh","year":"2008","journal-title":"Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0105","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0223-5234(00)80028-8","article-title":"Carbonic anhydrase inhibitors. Part 60(#). The topical intraocular pressure-lowering properties of metal complexes of a heterocyclic sulfonamide: influence of the metal ion upon biological activity","volume":"34","author":"Supuran","year":"1999","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0110","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.bmc.2012.11.004","article-title":"QSAR studies of sulfamate and sulfamide inhibitors targeting human carbonic anhydrase isozymes I II IX and XII","volume":"21","author":"Tarko","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0115","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/ci600469w","article-title":"Analysis of human carbonic anhydrase II: docking reliability and receptor-based 3D-QSAR study","volume":"47","author":"Tuccinardi","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2013.04.035","article-title":"Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis","volume":"66","author":"Wang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0125","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/ci600298r","article-title":"3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors","volume":"46","author":"Weber","year":"2006","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiolchem.2017.09.006_bib0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejmech.2013.10.081","volume":"71","author":"Zolnowska","year":"2014","journal-title":"Eur. J. Med. Chem."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927117302967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927117302967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T14:54:44Z","timestamp":1538664884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927117302967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":26,"alternative-id":["S1476927117302967"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2017.09.006","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QSAR study of pyrazolo[4,3-e][1,2,4]triazine sulfonamides against tumor-associated human carbonic anhydrase isoforms IX and XII","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2017.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}